Please login to the form below

Not currently logged in
Email:
Password:

Mereo BioPharma appoints CFO

Richard Jones joins the rare diseases specialist

London, UK-based Mereo BioPharma Group has appointed Richard Jones as chief financial officer and member of the board of directors, effective from early 2017.

Jones joins the rare and specialty diseases clinical-stage company from Shield Therapeutics, where he most recently served as chief financial officer and company secretary.

Prior to this, Jones worked in investment banking and specialised in advising healthcare clients. He held a number of senior positions as Brewin Dolphin Securities, Investec and PricewaterhouseCoopers.

Dr Denise Scots-Knight, chief executive of Mereo BioPharma, said: “I am delighted to announce the appointment of Richard Jones as our chief financial officer and to the board of directors.

“His extensive financial experience in healthcare industry, initially as an investment banker in the sector and more recently as chief financial officer of Shield Therapeutic, complements that of the other members of Mereo's executive team.

“Following our positive debut as a listed company, the board is confident that Richard will make a valuable and significant contribution to Mereo's future success.”

21st November 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

3 reasons why clinical trials will thrive in 2021
It’s not often that a single event can change the trajectory of an entire system, yet that is exactly what has happened to healthcare systems across the world and clinical...
#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...

Infographics